🇺🇸
United States · US · US:50458-611_2e6ef0e1-19d2-7d78-e063-6394a90ae8a6
INVEGA HAFYERA
Orange BookUNIISPLATC N05AX13
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerJanssen Pharmaceuticals, Inc
CountryUS (United States)
ATC codeN05AX13
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 1
- ndc1150458611011 SYRINGE in 1 CARTON (50458-611-01) / 3.5 mL in 1 SYRINGE
Annotations
UNII (FDA Substance ID)
R8P8USM8FR
PALIPERIDONE PALMITATE
RxCUI 858045
Orange Book
N207946
DailyMed SPL labels
1 version tracked
Raw payload (JSON)
{
"unii": {
"unii": "R8P8USM8FR",
"rxcui": "858045",
"inchikey": "VOMKSBFLAZZBOW-UHFFFAOYSA-N",
"display_name": "PALIPERIDONE PALMITATE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "INTRAMUSCULAR",
"spl_meta": {
"7b8e5b26-b9e4-4704-921b-3c3c0d159916": {
"match": "brand_token",
"title": "INVEGA (PALIPERIDONE) TABLET, EXTENDED RELEASE [JANSSEN PHARMACEUTICALS, INC.]",
"spl_version": "43",
"published_date": "2026-03-20"
}
},
"productid": "50458-611_2e6ef0e1-19d2-7d78-e063-6394a90ae8a6",
"productndc": "50458-611",
"dosage_form": "INJECTION, SUSPENSION, EXTENDED RELEASE",
"orange_book": {
"appl_no": "207946",
"products": [
{
"rs": true,
"rld": true,
"te_code": null,
"strength": "273MG/0.875ML (273MG/0.875ML)",
"product_no": "001",
"approval_date": "May 18, 2015"
},
{
"rs": true,
"rld": true,
"te_code": null,
"strength": "410MG/1.315ML (311.79MG/ML)",
"product_no": "002",
"approval_date": "May 18, 2015"
},
{
"rs": true,
"rld": true,
"te_code": null,
"strength": "546MG/1.75ML (312MG/ML)",
"product_no": "003",
"approval_date": "May 18, 2015"
},
{
"rs": true,
"rld": true,
"te_code": null,
"strength": "819MG/2.625ML (312MG/ML)",
"product_no": "004",
"approval_date": "May 18, 2015"
},
{
"rs": true,
"rld": true,
"te_code": null,
"strength": "1.092GM/3.5ML (312MG/ML)",
"product_no": "005",
"approval_date": "Aug 30, 2021"
},
{
"rs": true,
"rld": true,
"te_code": null,
"strength": "1.560GM/5ML (312MG/ML)",
"product_no": "006",
"approval_date": "Aug 30, 2021"
}
],
"appl_type": "N"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "PALIPERIDONE PALMITATE",
"proprietary_name": "INVEGA HAFYERA",
"active_ingred_unit": "mg/3.5mL",
"application_number": "NDA207946",
"marketing_category": "NDA",
"nonproprietary_name": "paliperidone palmitate",
"start_marketing_date": "20210830",
"active_numerator_strength": "1092"
}Related drugs
Other records sharing ATC code N05AX13.
- CZBYANNLIJanssen-Cilag International N.V., Beerse
- FIBYANNLIJanssen-Cilag International NV
- PLBYANNLIJanssen-Cilag International N.V.
- DKBYANNLIJanssen-Cilag International NV
- ISBYANNLIJanssen-Cilag International NV*
- DKBYANNLIJanssen-Cilag International NV
- ISBYANNLIJanssen-Cilag International NV*
- CZBYANNLIJanssen-Cilag International N.V., Beerse
Access this data programmatically
Query INVEGA HAFYERA and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.